Please use this identifier to cite or link to this item: http://dl.umsu.ac.ir/handle/Hannan/187760
Title: Adverse Reactions to Biologic Therapy
Authors: Patel, Sheenal V.;Khan, David a.
subject: Biologic agents;Delayed reaction;Drug desensitization;Infusion reaction;Monoclonal antibodies;Omalizumab;Rituximab
Year: 2017
Publisher: 
Abstract: Biologic therapies are emerging as a significant therapeutic option for many with debilitating inflammatory and autoimmune conditions. As expansion in the number of FDA-approved agents continue to be seen, more unanticipated adverse reactions are likely t
URI: 
http://78.39.227.9/handle/Hannan/98298
http://dl.umsu.ac.ir/handle/Hannan/187760
ISSN: 
volume: Volume 37
issue: Issue 2
month: May
Appears in Collections:Immunology and Allergy Clinics of North America 2017

Files in This Item:
File Description SizeFormat 
2017 IACNA Volume 37 Issue 2 May (14).pdf223.22 kBAdobe PDFThumbnail
Download    Request a copy


Items in HannanDL are protected by copyright, with all rights reserved, unless otherwise indicated.